Trials / Withdrawn
WithdrawnNCT00511212
Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract
Clinical Study of Intravenous Immunoglobulin (IVIG) in Combination Therapy With Antibacterial Agents for Surgical Site Infection of the Lower Digestive Tract
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the clinical usefulness of IVIG in combination therapy with antibacterial agents for severe peritonitis after lower digestive tract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intravenous immunoglobulin |
Timeline
- Start date
- 2007-08-01
- Completion
- 2009-06-01
- First posted
- 2007-08-03
- Last updated
- 2011-07-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00511212. Inclusion in this directory is not an endorsement.